Vbi vaccines inc/bc (VBIV)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15
CASH FLOWS FROM OPERATING ACTIVITIES
NET LOSS

-54,813

-63,600

-38,995

-23,205

-26,193

Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization

1,204

542

730

606

492

Impairment charges

6,292

278

-

-

-

Impairment of intangible assets

-

-

300

-

-

Non-cash interest on related party loans

-

-

-

0

469

Impairment of intangible assets

-

-

-

0

0

Stock-based compensation

3,935

3,312

2,410

2,521

2,127

Amortization of debt discount

998

1,274

1,181

109

0

Deferred taxes

-

-

-431

-1,780

0

Stock issued for in-process research and development acquisition expense

-

-

-

0

13,814

Inventory reserve

300

189

217

-341

0

Net change in operating working capital items:
Change in accounts receivable

136

-79

127

113

0

Change in inventory

385

378

89

93

-511

Change in prepaid expenses

-326

285

265

396

253

Change in other current assets

-57

-213

230

-763

-71

Change in other long-term assets

-6

31

14

221

10

Change in operating right of use assets

-982

-

-

-

-

Change in accounts payable

-5,175

3,804

-675

11

20

Change in deferred revenues

-1,694

4,924

-107

-

-

Increase (decrease) in deferred revenues

-

-

-

-15

-140

Change in other current liabilities

374

4,146

4,714

2,729

0

Payments made on operating lease liabilities

983

-

-

-

-

Net cash flows used in operating activities

-48,712

-45,533

-31,381

-18,517

-9,092

INVESTING ACTIVITIES
Cash acquired in acquisitions

-

-

-

2,126

20,872

Changes in other long-term assets

-

-

-61

41

-23

Purchase of property and equipment

3,673

5,993

640

585

583

Net cash flows used in investing activities

-3,673

-5,993

-579

1,500

20,312

FINANCING ACTIVITIES
Proceeds from issuance of common shares for cash

40,250

46,558

71,905

24,209

0

Share issuance costs

2,835

3,006

4,683

100

0

Proceeds from issuance of common shares for cash, upon exercise of stock options

-

65

16

59

0

Proceeds from long-term loan and issuance of warrants net of $360 of financing costs - related party

-

-

-

12,840

0

Repayment of long-term debt

-

-

-

525

0

Loan received from related parties

-

-

-

0

2,025

Loans repaid to related parties

-

-

-

0

1,475

Net cash flows used in financing activities

37,415

43,617

67,238

36,483

550

Effect of exchange rates on cash

-87

-515

134

-

-

CHANGE IN CASH FOR THE PERIOD

-15,057

-8,424

35,412

-

-

Effect of exchange rates on cash

-

-

-

340

84

CHANGE IN CASH FOR THE PERIOD

-

-

-

19,806

11,854

Supplementary information:
Interest paid - related party

2,033

1,980

1,850

283

0

Non-cash investing and financing activities:
Warrant modification in connection with debt amendment

179

386

-

-

-

Capital expenditures included in accounts payable and other current liabilities

33

1,552

145

-

-

Share issuance costs included in accounts payable and other current liabilities

-

-146

-

-

-

Shares issued for loans assigned by related party

-

-

-

0

10,611

Issuance of shares in reverse takeover

-

-

-

0

20,878

Common shares, options and warrants issued for acquisition of VBI

-

-

-

67,494

0

Shares issued as part of settlement agreement with Kevelt

-

-

-

0

0

Warrants issued in connection with financing transaction

-

-

-

0

0

Purchase of property and equipment in accounts payable

-

-

-

0

0